Skip to main content Skip to section navigation
Back to Top

Division of Interdisciplinary Brain Sciences

group picture



The Division of Interdisciplinary Brain Sciences brings together faculty in psychiatry, psychology, statistics, and computational neuroscience, whose collective efforts are committed to the following:

  • Leveraging interdisciplinary knowledge to provide explanatory models for human behavior that captures the inherent complexity of genetic, biological, and environmental factors
  • Developing innovative methods for studying the brain and behavior and applying these tools to better understand brain – behavior associations underlying cognitive, developmental and neuropsychiatric impairments
  • Addressing an individual as a whole person undergoing unique trajectories of development, across all stages of the lifespan


Psychiatry is currently undergoing a dramatic transformation, as earlier models of defining psychiatric disorders are evolving to incorporate a rapidly expanding knowledge base of mechanisms underlying human cognition and behavior. Faculty within the Division of Interdisciplinary Brain Sciences believe this dynamic environment represents an incredible opportunity – an opening to rethink mental healthcare through the combination of clinical expertise with cutting-edge scientific research.

The ultimate goal of clinical activities within the Division aims to leverage advances in both these domains, with a constant focus on improving the lives of patients suffering from psychiatric illnesses. It is an unfortunate truth that many interventions in psychiatric practice continue to have relatively low rates of treatment response, meaning a disproportionate number of individuals continue to be affected by psychiatric symptoms, causing a substantial burden on their daily functioning and wellbeing.

To address these health disparities, clinical and research initiatives within the Division are focused on several key domains:

  1. Comprehensive treatment and evaluation of neurogenetic disorders, such as Fragile X syndrome and sex chromosome aneuploidies, as better understanding of these conditions with well defined causal mechanisms allows broader application to disease processes in more generalized psychiatric disorders with similar symptomatology;
  2. Development of transdiagnostic and lifespan approaches to classification of psychiatric disorders using innovative clinical and computational methods, thereby bypassing current reliance on phenomenological rather than mechanistic frameworks;
  3. Innovation in treatment intervention leveraging neurobiological principles, such as neurofeedback and biophysical measures, which extend beyond current mainstays of medications and psychosocial treatments.

David Hong, MD
Chief of the Division of Interdisciplinary Brain Sciences